Welcome to our dedicated page for Datasea Intelligent Technology news (Ticker: DTSS), a resource for investors and traders seeking the latest updates and insights on Datasea Intelligent Technology stock.
Datasea Intelligent Technology Ltd. develops acoustic high-tech products and AI-powered multimodal digital solutions through a public holding-company structure. Its news commonly covers acoustic applications using ultrasonic, infrasound and directional sound technologies, including acoustic disinfection products, wellness care robots, environmental hygiene uses and research-stage industrial applications.
Company updates also address AI multimodal solution projects, 5G-AI digitalization, partner-supported commercialization, U.S. market activity through Datasea Acoustics LLC, and periodic financial results. The company completed a redomicile merger from Nevada to the British Virgin Islands in 2026, with the BVI company continuing as the Nasdaq-listed public holding company under DTSS.
Datasea (NASDAQ: DTSS) announced progress on two acoustic-driven brain–computer interface (BCI) initiatives on Jan 12, 2026, targeting assistive communication for neurological patients and upper-limb rehabilitation robot control. The work advances acoustic-enabled BCI from signal acquisition toward system-level integration by combining acoustic signal enhancement, EEG feature selection, flexible MXene electrodes, and transcranial closed-loop ultrasound modulation.
The company said it has begun collaborations with domestic health robotics firms, including Nanjing Linghang, to validate integration and explore commercialization amid a projected global BCI market of USD 15–20 billion by 2030.
Datasea (OTC:DTSS) announced on January 5, 2026 a strategic collaboration between its China subsidiary Datasea Jingwei and Nanjing Linghang Intelligent Aviation Technology to explore applying Datasea's acoustic enhancement technologies to non-invasive brain–computer interface (BCI) and healthcare robot systems.
The agreement covers system integration validation, engineering testing, and application exploration aimed at improving EEG signal stability and decoding accuracy, supporting future productization for rehabilitation and healthcare services. The release cites industry forecasts that the global BCI market could reach USD 15–20 billion by 2030.
Datasea (NASDAQ: DTSS) announced a strategic partnership with Shenzhen Yizhimei on Dec 17, 2025 to deploy an Acoustics + AI-driven Beauty & Health Intelligence System and an Acoustics Digital AI Shampooing Robot across a nationwide store network.
Key commercial terms include system settlement fees ≥0.1% of online transaction flows, 3% technology service fees on gross sales from an initial cohort of 3,000 designated stores, 0.5% e-commerce platform fees, and a minimum annual revenue guarantee of RMB 1.2 million. Datasea positions the deployment to address China's Beauty & Health market estimated at RMB 1.5 trillion (~USD 210B).
Datasea (NASDAQ: DTSS) announced engineering-stage completion of two acoustic-driven brain–computer interface technologies on December 11, 2025: a Real-Time Closed-Loop Vibration-Enhanced BCI System and an Acoustic-Coupled EEG Signal Enhancement System. The systems provide an integrated framework for brain-signal acquisition, decoding, feedback modulation, missing-signal reconstruction, and acoustic-field enhancement.
The company says these technologies aim to improve EEG SNR, dynamic decoding of signals (eg, motor intention), and closed-loop responsiveness, with potential future applications in healthcare, neuromodulation, rehabilitation, consumer wellness devices, and human–machine interaction, subject to further development, validation, and regulatory review.
Datasea (NASDAQ: DTSS) issued a statement on Nov 18, 2025 addressing recent trading activity and reaffirming that operations remain normal and the company's business and financial position are solid.
The company reported Q1 2026 gross profit of USD 1.17 million, a 4.9x year-over-year increase, and a gross margin of 8.46%, which management says reflects a shift toward higher-margin, technology-driven solutions. Management said it is not aware of any undisclosed material information explaining recent share-price and volume fluctuations and is evaluating strategic measures to help the market better recognize the company’s value.
Datasea highlighted recent technological progress in acoustic technologies and brain–computer interface applications and reiterated that investor communications will be made through official SEC filings and authorized releases.
Datasea (Nasdaq: DTSS) reported unaudited results for the quarter ended September 30, 2025. Revenue was $13.81 million, down 34.5% year‑over‑year as the company restructured toward higher‑margin technology services. Gross profit rose to $1.17 million (about 5.9x prior year) and gross margin improved to 8.46% from 0.93%, driven by higher contribution from 5G+AI multimodal digital solutions and acoustic products. The 5G+AI segment generated $13.32 million, with new vertical solutions contributing RMB 6.53 million (~USD 0.92 million). Management emphasized a strategic pivot from scale to profitability and continued R&D in acoustic AI and neuro‑regulation.
Datasea (NASDAQ: DTSS) reported remarkable financial results for fiscal year 2025, with revenue surging 198.7% to $71.62 million from $23.97 million in FY2024. The company achieved significant milestones, including a 415.5% increase in gross profit to $2.44 million and reaching net income breakeven in Q4 FY2025 (adjusted for non-cash items).
The growth was driven by two core segments: AI Multimodal Digitalization, which generated $70.68 million in revenue (199.49% YoY increase), and Acoustic High-Tech solutions. The company expanded its core client base from 8 to 15 large enterprises and deployed acoustic products across 463 beauty and health stores. Datasea's intangible assets grew 540.3% to $3.50 million, reflecting successful strategic transformation.
Datasea (NASDAQ: DTSS) has signed a significant 12-month service agreement with Hainan Zhixingjian for acoustic smart health shoes technology. The company will provide proprietary acoustic health hardware and software solutions for smart health insoles, incorporating features like heating, weight monitoring, and ultrasonic sterilization.
Under the agreement, Datasea will receive RMB 9 ($1.26) per pair of shoes produced, reducing to RMB 7 ($0.98) if production exceeds 1 million pairs. The contract includes a minimum guaranteed fee of RMB 500,000 ($70,224) and is expected to generate up to RMB 7 million ($0.98 million) in technology service fees. This marks Datasea's strategic shift from hardware sales to a high-margin, solution-driven growth model in the health wearables market.
Datasea (NASDAQ: DTSS) announced a significant breakthrough in acoustic technology, integrating sound wave coupling with AI for healthcare applications. The company has developed technology for precise regulation of nervous system functions, including intracranial, peripheral, and cardiac areas, creating a closed-loop ecosystem for medical interventions.
The company is targeting a substantial market opportunity projected to reach over $100 billion in China and $90 billion globally by 2030. Datasea has positioned ultrasound neuromodulation as its core product strategy and has begun initial commercialization phases with medical-grade precision hardware products.